TalkMarkets Newswire | TalkMarkets | Page 1
Company News & Information
TalkMarkets Newswire is a premier service which disseminates and distributes critical news, press releases and information about a variety of companies. This information is seen by readers not only on TalkMarkets, but also goes out to our distribution partners which include such leading companies ...more

All Contributions

Latest Posts
1 to 16 of 35 Posts
TalkMarkets Announces Company Spotlight Featuring SaverOne announces a company spotlight series featuring SaverOne (NASDAQ: SVRE), a startup company in the the self-driving EV space, with an attractive risk/reward ratio.
TalkMarkets Announces Company Spotlight Featuring Evogene announces a company spotlight series featuring Evogene (NASDAQ: EVGN), an agri-tech and bio-tech company with a computational predictive biological platform technology.
TalkMarkets Announces Company Spotlight Featuring Adamas One announces a company spotlight series featuring Adamas One (NASDAQ: JEWL), a leading producer of lab-grown diamonds.
Biomica Announces Closing Of $20 Million Financing Round Led By Shanghai Healthcare Capital
Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), today announced that it has closed a financing round of $20 million
RenovoRx Announces Positive New Data From Phase III Clinical Trial Interim Analysis: 60% Survival Benefit And Fewer Side Effects Than Systemic Chemotherapy
RenovoGem patients had greater than 65% reduction in side effects, which can include nausea, fatigue, and reduced white blood cells during pancreatic cancer treatment.
RenovoRx’s Principal Investigator Of Phase III Clinical Trial Discusses Positive Interim Results On Patients With Locally Advanced Pancreatic Cancer On OncologyTube
In the interview, Dr. Michael Pishvaian discussed the trial's potential impact on the oncology community as well as how pancreatic cancer patients are treated.
BriaCell Announces Positive End Of Phase II Meeting With The FDA For Bria-IMT(TM) Combination In Advanced Metastatic Breast Cancer
Registration study success could lead to a Biologics License Application (BLA) submission and commercialization approvals for BriaCell’s novel immunotherapy approach.
SurgePays Passes 150,000 Mobile Broadband Subscribers
SurgePays, a technology and telecommunications company focused on the underbanked and underserved, announces it exceeded 150,000 subscribers in its mobile broadband subscriber business SurgePhone Wireless LLC.
SurgePays Announces The Acquisition Of Torch Wireless
SURG announced today the acquisition of Torch Wireless, a provider of wireless broadband with the FCC’s Affordable Connectivity Program (ACP) in a cash and limited royalties deal.
DarioHealth Enters Into Strategic Agreement With Sanofi U.S.
Novel Strategic Agreement focuses on commercial growth for Dario and the development of Digital Health Solutions on Dario’s platform.
Legacy Education Alliance Teams Up With The Cash Flow Academy
Legacy Education Alliance, Inc. announced that it has entered into a marketing and fulfillment agreement with The Cash Flow Academy.
DarioHealth Announces Two New Contracts Within The Employer Market
Dario's new employer clients include a contract for its full suite of digital therapeutic solutions.
SinglePoint Inc. Announces Updated Q4 2021 Revenue Milestones And Annual Revenue Projections For Solar-Centric Businesses For FY2022
SinglePoint Inc., today provided an update on forward-looking revenue guidance goals for the Company's solar-centric subsidiaries for Q4 2021
SurgePays, Inc. Expands Sales Activities Via The Launch Of BLITZ, The Company’s Proprietary Blockchain Supported Sales Funnel, Customer Relationship Management And Business Intelligence Platform And The Appointment Of In-House Sales Team Leaders
SURG announces the expansion of sales activities by strategically centralizing its sales operations and the launch of the Company’s proprietary, blockchain-supported sales funnel, CRM, and BI platform, BLITZ.
CNS Pharmaceuticals Commences Patient Enrollment In Potentially Pivotal Study Of Berubicin
CNS Pharmaceuticals today announced open enrollment for its potentially pivotal study evaluating the efficacy and safety of Berubicin in the treatment of recurrent GBM.
American Resources Corporation Selected As A Consortium Member In U.S. Department Of Energy Contract To Assess Northern Appalachian Critical And Rare Earth Elements
American Resources Corporation is a next-generation, environmentally, and socially responsible supplier of high-quality raw materials to the new infrastructure market.
1 to 16 of 35 Posts